How will Trump’s election change the FDA? History yields some clues

Taking stock of the drug industry, from the lab to the medicine chest

November 6, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Anna Moneymaker/Getty Images STAT+ | How will Trump's election change the FDA? History yields some clues During Trump's first term, the most radical potential changes were generally averted because of institutional forces. This time could be different. By Matthew Herper STAT+ | Biotech and pharma executives on what Trump and RFK Jr. could mean for the industry How Trump's presidency will shape the biotech and pharma outlook, according to CEOs of Teva, Bausch + Lomb, GSK, Novo Nordisk, and more. By Allison DeAngelis, Matthew Herper, Andrew Joseph, Jason Mast, and Ed Silverman STAT+ | What letting RFK Jr. 'go wild' might mean for Trump's FDA Experts say Donald Trump and RFK Jr. could radically alter the Food and Drug Administration, the nation's top regulator of vaccines, drugs, and food. By Lizzy Lawrence Adobe Opinion: Pharma's ethically questionable sites essentially sell drugs directly to consumers Some of the largest pharmaceutical companies in the U.S. are piloting websites that essentially sell their drugs directly to consumers. It's unethical. By Adriane Fugh-Berman and Judy Butler

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser